07 Jan 2026 Expanding Our NGS solutions: Analis & GeneMind announce their Exclusive Partnership Multiple categories
05 Jan 2026 argenx announces leadership transition marking next evolution of growth Multiple categories
18 Dec 2025 Confo Therapeutics Nominates SSTR5 Agonist Antibody CFTX-2034 as Development Candidate for Post-Bariatric Hypoglycemia Multiple categories
27 Nov 2025 Obulytix Strengthens Senior Leadership with Key Executive and Board Appointments Multiple categories
25 Nov 2025 Allegro and American Regent sign exclusive licensing deal for SynoglideTM, a novel osteoarthritis treatment in animal health, valued at up to $35 million Multiple categories
20 Nov 2025 Gevers strengthens its leadership position with the acquisition of patent firm Pecher & Partners Member news
19 Nov 2025 P95 and Julius Clinical Merge to Form Global, Science-Led CRO Delivering Integrated Clinical Development and Real-World Evidence Multiple categories
13 Nov 2025 Tebubio Partners with 4Dcell to Expand Access to Advanced 3D Cell Culture, “NAMs”, Technologies Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
